These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2730683

  • 1. Modification of vesicular dopamine and norepinephrine by monoamine oxidase inhibitors.
    Buu NT.
    Biochem Pharmacol; 1989 May 15; 38(10):1685-92. PubMed ID: 2730683
    [Abstract] [Full Text] [Related]

  • 2. Vesicular accumulation of dopamine following L-DOPA administration.
    Buu NT.
    Biochem Pharmacol; 1989 Jun 01; 38(11):1787-92. PubMed ID: 2735936
    [Abstract] [Full Text] [Related]

  • 3. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul 01; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 4. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB, Angers M.
    Biochem Pharmacol; 1987 May 15; 36(10):1731-5. PubMed ID: 3109430
    [Abstract] [Full Text] [Related]

  • 5. Modification of dopamine and norepinephrine metabolism in the rat brain by monoamine oxidase inhibitors.
    Buu NT, Angers M, Duhaime J, Kuchel O.
    J Neural Transm; 1987 May 15; 70(1-2):39-50. PubMed ID: 3668521
    [Abstract] [Full Text] [Related]

  • 6. Vesicular and ganglionic norepinephrine in the rat: progressive increase with age.
    Buu NT, Debinski W.
    J Neurochem; 1990 Feb 15; 54(2):620-6. PubMed ID: 2299355
    [Abstract] [Full Text] [Related]

  • 7. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
    Buu NT, Lussier C.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 Feb 15; 13(3-4):563-8. PubMed ID: 2748880
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
    Mefford IN, Roth KA, Jurik SM, Collman V, McIntire S, Tolbert L, Barchas JD.
    Brain Res; 1985 Jul 29; 339(2):342-5. PubMed ID: 2411347
    [Abstract] [Full Text] [Related]

  • 15. Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors.
    Juorio AV, Greenshaw AJ, Wishart TB.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec 29; 338(6):644-8. PubMed ID: 3149722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine sulfoconjugation in the rat brain: regulation by monoamine oxidase.
    Buu NT.
    J Neurochem; 1985 Aug 29; 45(2):470-6. PubMed ID: 3925084
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.